Phase II Single Arm Study of Gemcitabine and Cisplatin plus Pembrolizumab as Neoadjuvant Therapy Prior to Radical Cystectomy in Patients with Muscle-Invasive Bladder Cancer
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
University of North Carolina - Chapel Hill
Start Date
April 17, 2018
End Date
April 30, 2023
Administered By
Duke Cancer Institute
Awarded By
University of North Carolina - Chapel Hill
Start Date
April 17, 2018
End Date
April 30, 2023